GLOBAL RESEARCH ARCHIVE
Teradata: 2Q26 Earnings - Looking For a Stronger 2H
Research evidence excerpt
M
Update
August 5, 2026 02:24 AM GMT
Morgan Stanley & Co. LLC
Teradata | North America
Erik W Woodring
Equity Analyst
2Q26 Earnings - Looking For a
Stronger 2H
Rauf Ural
Research Associate
Maya C Neuman
Research Associate
What’s Changed
Teradata (TDC.N)
From
To
Price Target
$40.00
$35.00
Dylan Liu
Research Associate
Teradata (TDC.N, TDC UN)
AlphaSignals Earnings Reaction
IT Hardware | United States of America
Unchanged
Modest upside
Modest revision higher
Impact to our thesis
Financial results versus consensus
Direction of next 12-month
consensus EPS
Source: Company data, Morgan Stanley Research
1H fundamentals were better than expected, but the flowthrough to 2H isn't materializing despite mgmt's positive tone on
platform adoption, new products, and customer wins. CY26 EPS
moves modestly higher thanks to 2Q beat, but 2H
outperformance is required to get valuation back on track.
Key Takeaways
2Q beat on revenue, recurring revenue, EPS and FCF; full-year EPS and FCF
guides move higher, marking continued execution.
Stock Rating
Industry View
Price target
Shr price, close (Aug 4, 2026)
Mkt cap, curr (mm)
52-Week Range
Fiscal Year Ending
12/25 12/26e 12/27e 12/28e
ModelWare EPS ($)
Prior ModelWare EPS
($)
P/E
EPS ($)§
Div yld (%)
EPS ($)**
Prior EPS ($)**
Quarterly EPS ($)
seeing accelerated growth; 2H strength required to get valuation back on track.
Quarter
2025
Q1
Q2
Q3
Q4
0.66
0.47
0.72
0.74
rates strengthening, and pipeline growing across TDC Factory, AI Studio, and
more.
2.58
2.70
2.63
2.90
2.84
3.15
2.98
11.8
2.40
2.58
12.7
2.67
2.70
2.63
11.9
2.89
2.90
2.84
10.9
3.24
3.15
2.98
Unless otherwise noted, all metrics are based on Morgan Stanley ModelWare
framework
§ = Consensus data is provided by Refinitiv Estimates
** = Based on consensus methodology
e = Morgan Stanley Research estimates
But, we were looking for a stronger 2H in a world where AI beneficiaries are
Underlying fundamentals solid: deferred revs +8% Y/Y, RPO improving, renewal
Overweight
Cautious
$35.00
$34.39
$3,274
$41.70-19.99
2026e 2026e
Prior Current
0.66
0.62
0.88a
0.69a
0.58
0.56
2027e 2027e
Prior Current
0.69
0.72
0.74
0.71
0.73
0.75
…
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer